Adi Mor
Algemeen Directeur bij CHEMOMAB THERAPEUTICS LTD.
Vermogen: 30 400 $ op 31-05-2024
Actieve functies van Adi Mor
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Directeur/Bestuurslid | 22-09-2011 | - |
| Algemeen Directeur | 01-06-2023 | - | |
| Hoofd Techniek/Wetenschap/O&O | 22-09-2011 | - | |
| Oprichter | 22-09-2011 | - | |
Chemomab Ltd.
 Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Directeur/Bestuurslid | 01-01-2011 | - |
| Algemeen Directeur | 01-01-2011 | - | |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2011 | - | |
| Oprichter | 01-01-2011 | - |
Loopbaan van Adi Mor
Opleiding van Adi Mor
| Tel-Aviv University | Doctorate Degree |
Statistieken
Internationaal
| Israël | 4 |
Operationeel
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Chemomab Ltd.
Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Health Technology |
